Literature DB >> 7737222

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety.

J Shepherd1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7737222     DOI： 10.1093/eurheartj/16.1.5

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  16 in total

Review 1.  Comparing HMG-CoA reductase inhibitors.

Authors:  Peter H Jones
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

2.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

3.  Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.

Authors:  Amir Hooshang Mohammadpour; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

Review 4.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Statins: is there a need for alternative or adjunctive therapy?

Authors:  J Shepherd
Journal:  Br Heart J       Date:  1995-07

Review 6.  Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.

Authors:  T K Lau; D R Leachman; R Lufschanowski
Journal:  Tex Heart Inst J       Date:  2001

Review 7.  Clinical pharmacokinetics of fibric acid derivatives (fibrates).

Authors:  D B Miller; J D Spence
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 8.  The 4S study. Implications for prescribing.

Authors:  A J van Boven; J Brügemann; P A de Graeff; J F May; H J Crijns
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

9.  Atorvastatin versus Bezafibrate in Mixed Hyperlipidaemia : Randomised Clinical Trial of Efficacy and Safety (the ATOMIX Study).

Authors:  Emilio Ros; Josefina Oliván; José M Mostaza; Miquel Vilardell; Xavier Pintó; Fernando Civeira; A Hernández; Pedro Marqués da Silva; A Rodriguez-Botaro; Daniel Zambón; Joan Lima; José A Gómez-Gerique; Cristina Díaz; Rosa Arístegui; José M Sol; Gonzalo Hernández
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  The effects of an omega-3 ethyl ester concentrate on blood lipid concentrations in patients with hyperlipidaemia.

Authors:  L Borthwick
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.